Sunflower Therapeutics

United States
West Bend, Iowa, United States, 02043

Company profile

Sunflower Therapeutics company profile

Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions. Its aimis to improve patient access to biological medicines around the world by developing and manufacturing emerging technologies that benefit the whole global population. Using strain engineering, integrated process development, and automated multi-product facilities, they are developing the right-sized and efficient ways to produce protein. Wellness, integrity, ethics, equity, community, and efficiency are all important to them.

Business identity

Contact email
[email protected]
Phone number
+1 617 653 5061
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
02043
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
4
Total equity funding
$3M
Last funding
Grant / $300,000 / 2025-09-03
Last equity funding
Seed / $3M
Investors
4
Lead investors
3
Articles
24

Founders and investors

Lead investors

Bill & Melinda Gates FoundationNational Institute of Allergy and Infectious DiseasesSK Bioscience

Investors

Bill & Melinda Gates FoundationEmerald Development ManagersNational Institute of Allergy and Infectious DiseasesSK Bioscience